MEDIWATCH

Please read the posts for the month of April 2009 where updates and information relating to Mediwatch the company along with the field of Urology are stored. (EDIT 2013-A LOT OF UPDATING IS REQUIRED) This blog is set-up mainly to gather information relating to Mediwatch along with the sector they are involved in and IS IN NO WAY A RECOMMENDATION TO BUY SHARES IN THE COMPANY!

Saturday, 4 April 2009

PCA3 INFORMATION (Updated 24th May)

June 2008-Ground-breaking molecular test for prostate cancer-Agreement signed with Bostwick Labaoratories

Bostwick Laboratories


************************************************************************************

Prostate Cancer: Detection & Screening - Feasibility of the PCA3 Urine Test in a Community Based Screening Setting AUA 2009

PROSTATE CANCER DIAGNOSIS: STRENGTHS AND WEAKNESSES OF PROSTATE-SPECIFIC ANTIGEN AND THE DISCOVERY AND CLINICAL EVALUATION OF PROSTATE CANCER GENE 3 (PCA3) March 2009

The PCA3 test-A success story from laboratory to market place March 2009



Apr.2008-Laboratory Industry Report-on Bostwick

Prostate Cancer Gene 3 (PCA3) website
Banjomick at 15:17

No comments:

Post a Comment

‹
›
Home
View web version

About Me

Banjomick
Long-term investor. I set up this blog to gather information about MDW and the sector in general. Please,PLEASE DO NOT USE my posts as a reason to buy shares in MDW! I am happy to hold and add to my investment and can afford to lose it all if things go wrong as nothing is certain in this world! I do hope this blog will aid to any investment decissions though and more importantly it may be of use for anyone wanting to gather information for non-financial reasons!
View my complete profile
Powered by Blogger.